vs

Side-by-side financial comparison of Merchants Bancorp (MBIN) and Oncology Institute, Inc. (TOI). Click either name above to swap in a different company.

Merchants Bancorp is the larger business by last-quarter revenue ($175.2M vs $142.0M, roughly 1.2× Oncology Institute, Inc.). Merchants Bancorp runs the higher net margin — 38.6% vs -5.3%, a 43.9% gap on every dollar of revenue. Over the past eight quarters, Oncology Institute, Inc.'s revenue compounded faster (22.5% CAGR vs 4.8%).

Ameris Bancorp is an American bank holding company headquartered in Atlanta, Georgia. Through its bank subsidiary, Ameris Bank, the company operates full-service branches in Georgia, Alabama, Florida, North Carolina and South Carolina, and mortgage-only locations in Georgia, Alabama, Florida, North Carolina, South Carolina, Virginia, Maryland, and Tennessee. The company offers online and mobile banking options for both consumers and businesses.

Oncology Institute, Inc. is a specialized healthcare enterprise focused on delivering patient-centric, evidence-based oncology care services, including advanced treatment regimens, clinical trial access, and supportive care programs. It primarily operates across the United States, serving patients with diverse cancer diagnoses and partnering with care teams to improve treatment outcomes.

MBIN vs TOI — Head-to-Head

Bigger by revenue
MBIN
MBIN
1.2× larger
MBIN
$175.2M
$142.0M
TOI
Higher net margin
MBIN
MBIN
43.9% more per $
MBIN
38.6%
-5.3%
TOI
Faster 2-yr revenue CAGR
TOI
TOI
Annualised
TOI
22.5%
4.8%
MBIN

Income Statement — Q1 FY2026 vs Q4 FY2025

Metric
MBIN
MBIN
TOI
TOI
Revenue
$175.2M
$142.0M
Net Profit
$67.7M
$-7.5M
Gross Margin
Operating Margin
-4.9%
Net Margin
38.6%
-5.3%
Revenue YoY
41.6%
Net Profit YoY
16.3%
43.0%
EPS (diluted)
$1.25
$-0.04

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
MBIN
MBIN
TOI
TOI
Q1 26
$175.2M
Q4 25
$185.3M
$142.0M
Q3 25
$171.1M
$136.6M
Q2 25
$179.2M
$119.8M
Q1 25
$145.9M
$104.4M
Q4 24
$193.8M
$100.3M
Q3 24
$149.6M
$99.9M
Q2 24
$159.5M
$98.6M
Net Profit
MBIN
MBIN
TOI
TOI
Q1 26
$67.7M
Q4 25
$-7.5M
Q3 25
$54.7M
$-16.5M
Q2 25
$38.0M
$-17.0M
Q1 25
$58.2M
$-19.6M
Q4 24
$-13.2M
Q3 24
$61.3M
$-16.1M
Q2 24
$76.4M
$-15.5M
Operating Margin
MBIN
MBIN
TOI
TOI
Q1 26
Q4 25
39.9%
-4.9%
Q3 25
37.8%
-5.9%
Q2 25
27.3%
-9.4%
Q1 25
52.4%
-9.5%
Q4 24
66.0%
-11.9%
Q3 24
54.4%
-13.9%
Q2 24
62.2%
-16.6%
Net Margin
MBIN
MBIN
TOI
TOI
Q1 26
38.6%
Q4 25
-5.3%
Q3 25
32.0%
-12.1%
Q2 25
21.2%
-14.2%
Q1 25
39.9%
-18.8%
Q4 24
-13.1%
Q3 24
41.0%
-16.1%
Q2 24
47.9%
-15.7%
EPS (diluted)
MBIN
MBIN
TOI
TOI
Q1 26
$1.25
Q4 25
$1.28
$-0.04
Q3 25
$0.97
$-0.14
Q2 25
$0.60
$-0.15
Q1 25
$0.93
$-0.21
Q4 24
$1.84
$-0.14
Q3 24
$1.17
$-0.18
Q2 24
$1.49
$-0.17

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
MBIN
MBIN
TOI
TOI
Cash + ST InvestmentsLiquidity on hand
$83.2M
Total DebtLower is stronger
$32.0M
Stockholders' EquityBook value
$2.3B
$-15.7M
Total Assets
$20.3B
$164.7M
Debt / EquityLower = less leverage
0.01×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
MBIN
MBIN
TOI
TOI
Q1 26
$83.2M
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
$9.9M
Total Debt
MBIN
MBIN
TOI
TOI
Q1 26
$32.0M
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
Stockholders' Equity
MBIN
MBIN
TOI
TOI
Q1 26
$2.3B
Q4 25
$2.3B
$-15.7M
Q3 25
$2.2B
$-12.3M
Q2 25
$2.2B
$-9.0M
Q1 25
$2.2B
$5.1M
Q4 24
$2.2B
$3.6M
Q3 24
$1.9B
$15.5M
Q2 24
$1.9B
$29.2M
Total Assets
MBIN
MBIN
TOI
TOI
Q1 26
$20.3B
Q4 25
$19.4B
$164.7M
Q3 25
$19.4B
$163.6M
Q2 25
$19.1B
$159.8M
Q1 25
$18.8B
$164.0M
Q4 24
$18.8B
$172.7M
Q3 24
$18.7B
$179.2M
Q2 24
$18.2B
$179.6M
Debt / Equity
MBIN
MBIN
TOI
TOI
Q1 26
0.01×
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
MBIN
MBIN
TOI
TOI
Operating Cash FlowLast quarter
$3.2M
Free Cash FlowOCF − Capex
$2.2M
FCF MarginFCF / Revenue
1.5%
Capex IntensityCapex / Revenue
0.7%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-27.8M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
MBIN
MBIN
TOI
TOI
Q1 26
Q4 25
$-341.2M
$3.2M
Q3 25
$29.8M
$-12.6M
Q2 25
$-121.2M
$-10.2M
Q1 25
$148.0M
$-5.0M
Q4 24
$-835.3M
$4.2M
Q3 24
$-492.6M
$819.0K
Q2 24
$51.1M
$-15.7M
Free Cash Flow
MBIN
MBIN
TOI
TOI
Q1 26
Q4 25
$-362.2M
$2.2M
Q3 25
$24.0M
$-13.2M
Q2 25
$-125.7M
$-11.4M
Q1 25
$141.2M
$-5.3M
Q4 24
$-853.7M
$2.4M
Q3 24
$-497.2M
$417.0K
Q2 24
$45.8M
$-17.5M
FCF Margin
MBIN
MBIN
TOI
TOI
Q1 26
Q4 25
-195.5%
1.5%
Q3 25
14.0%
-9.7%
Q2 25
-70.1%
-9.5%
Q1 25
96.8%
-5.1%
Q4 24
-440.6%
2.4%
Q3 24
-332.4%
0.4%
Q2 24
28.7%
-17.7%
Capex Intensity
MBIN
MBIN
TOI
TOI
Q1 26
Q4 25
11.3%
0.7%
Q3 25
3.4%
0.4%
Q2 25
2.5%
1.0%
Q1 25
4.7%
0.3%
Q4 24
9.5%
1.8%
Q3 24
3.0%
0.4%
Q2 24
3.3%
1.9%
Cash Conversion
MBIN
MBIN
TOI
TOI
Q1 26
Q4 25
Q3 25
0.54×
Q2 25
-3.19×
Q1 25
2.54×
Q4 24
Q3 24
-8.04×
Q2 24
0.67×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

MBIN
MBIN

Net Interest Income$128.6M73%
Noninterest Income$46.6M27%

TOI
TOI

Other$82.1M58%
Fee For Service$36.3M26%
Capitated Revenue$23.6M17%

Related Comparisons